Registration system for growth hormone (GH) treatment with standardized immunoreactive GH values in Japan

Endocrine Journal

Volumn 45, Issue 4, 1998, Pages 459-465

  Tanaka, Toshiaki ^a   Takano, Kazue ^b   Hanew, Kunihiko ^b   Nishi, Yoshikazu ^b   Igarashi, Yutaka ^b   Hirano, Takeki ^b   Saito, Tomohiro ^b   Tachibana, Katsuhiko ^b   Yokoya, Susumu ^b   Fujieda, Kenji ^b   Shimatsu, Akira ^b   Hizuka, Naomi ^b   Tsushima, Toshio ^b   Irie, Minoru ^b  

^a NATIONAL CHILDREN S HOSPITAL   (Japan)

^b NONE

Author keywords

Frequency of GHD; GH measurement; GH treatment; Registration system

Indexed keywords

ARGININE; CLONIDINE; GLUCAGON; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HUMAN GROWTH HORMONE; INSULIN; LEVODOPA; PROPRANOLOL; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; BODY HEIGHT; BONE AGE; CHILD; CLINICAL TRIAL; DRUG MARKETING; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH RATE; HORMONAL THERAPY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; NORMAL VALUE; PHARMACY AND THERAPEUTICS COMMITTEE; PRACTICE GUIDELINE; PROVOCATION TEST; RADIOIMMUNOASSAY; RECOMBINANT DNA TECHNOLOGY; REGISTRATION; SCORING SYSTEM; STANDARDIZATION;

EID: 7844246537     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.45.459     Document Type: Article

References (11)

1. Guidelines for the use of growth hormone in children with short stature (1995) A report by the Drug and Therapeutic Committee of the Lawson Wilkins Pediatric Endocrine Society. J Pediatr 127: 857-867.
2. Ogawa M, Yazawa T, Mori S (1992) Study on screening program for GHD. Report of the Study Group for Hypothalamo-pituitary Disorder of the Ministry of Health and Welfare, 291-293 (In Japanese).
3. Takano K, Tanaka T, Saito T (1994) Quality of life of growth hormone treated adults. Clin Pediatr Endocrinol 3 (Suppl 4): 47-53.
4. Takano K, Shizume K, Hibi I, Ogawa Y, Suwa S, Tanaka T (1993) Growth hormone treatment in Turner syndrome: Results of a multicentre study in Japan. Horm Res 39 (Suppl 2): 37-41.
5. Tanaka T, Takano K, Hanew K, Nishi Y, Fujieda K, Tachibana K, Yokoya S, Igarashi Y, Hirano T (1996) Spontaneous growth in growth hormone-treated short children. Endocr J 43 (Suppl): S135-S136.
6. Fujieda K, Hanew K, Hirano T, Igarashi Y, Nishi Y, Tachibana K, Takano K, Tanaka T, Yokoya S (1996) Growth responses to growth hormone therapy in patients with different degree of growth hormone deficiency. Endocr J 43 (Suppl): S19-S25.
7. Reiter EO, Morris AH, MacGillivray MH, Weber D (1988) Variable estimates of serum growth hormone concentrations by different radioassay systems. J Clin Endocrinol Metab 66: 68-71.
8. Blethen S, Chasalow F (1983) Use of a two-site immunoradiometric assay for growth hormone in identifying children with GH-dependent growth failure. J Clin Endocrinol Metab 57: 1031-1037.
9. Celnicker AC, Chen AB, Wert RBM, Sherman BM (1990) Variability of quantitation of circulating growth hormone using commercial immunoassays. J Clin Endocrinol Metab 68: 469-476.
10. Chatelain P, Bouillat B, Cohen R, Sassolas G, Souberbielle JC, Ruitton A, Joly MO, Job JC (1990) Assay of growth hormone levels in human plasma using commercial kits: Analysis of some factors influencing the results. Acta Paediatr Scand 370 (Suppl): 56-61.
11. Albertsson-Wikland K, Jansson C, Rosberg S, Novamo A (1993) Time-resolved immunofluorometric assay of human growth hormone. Clin Chem 39: 1620-1625.